Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves's Disease: A Case Report

被引：0
作者：
Yasin, Ahmed K. [1 ]
Abu-Tineh, Mohammad [2 ]
Alshurafa, Awni [2 ]
Ahmed, Khalid [2 ]
Abdulgayoom, Mohammed [2 ]
Afana, Mohammad [2 ]
Gameil, Amna [2 ]
Yassin, Mohamed A. [2 ]
机构：
[1] Hamad Med Corp, Dept Internal Med, Doha, Qatar
[2] Hamad Med Corp, Hematol & Bone Marrow Transplant BMT Sect, Dept Med Oncol, Natl Ctr Canc Care & Res, Doha, Qatar
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 02期
关键词：
hematology; chronic myeloid leukemia; case report; graves' disease; radioactive iodine; THERAPY;
D O I：
10.7759/cureus.35295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Therapy-related leukemia is an increasing concern in hematology. One of these substances that showed to increase the incidence of leukemia is radioactive iodine (RAI). We report here a case of radioactive iodine -induced chronic myeloid leukemia (CML) in a patient with Graves' disease, although most cases in the literature were for thyroid cancer. Also, our patient received a very low dose, which is unique compared to previous case reports in the literature.
引用
收藏
页数：5
相关论文
共 16 条
  • [1] Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project
    Abdulla, Mohammad A. J.
    Chandra, Prem
    El Akiki, Susanna
    Aldapt, Mahmood B.
    Sardar, Sundus
    Chapra, Ammar
    Nashwan, Abdulqadir J.
    Sorio, Claudio
    Tomasello, Luisa
    Boni, Christian
    Yassin, Mohamed A.
    [J]. CANCER CONTROL, 2021, 28
  • [2] Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
    Al-Dewik, N. Ader I.
    Morsi, Hisham M.
    Samara, Muthanna M.
    Ghasoub, Rola S.
    Gnanam, Cinquea C.
    Bhaskaran, Subi K.
    Nashwan, Abdulqadir J.
    Al-Jurf, Rana M.
    Ismail, Mohamed A.
    AlSharshani, Mohammed M.
    AlSayab, Ali A.
    Ben-Omran, Tawfeg I.
    Khatib, Rani B.
    Yassin, Mohamed A.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 95 - 104
  • [3] Al-Dewik NI., 2014, QSCI CONNECT, V2014, P24, DOI [10.5339/connect.2014.24, DOI 10.5339/CONNECT.2014.24]
  • [4] Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine
    Alfiar, F
    Amato, D
    Lipton, JH
    [J]. LEUKEMIA & LYMPHOMA, 1997, 27 (3-4) : 365 - 367
  • [5] Gastrointestinal Manifestations of CML: A Systematic Review
    Ali, Elrazi Awadel Karim
    Mushtaq, Kamran
    Sardar, Sundus
    Abdelmahmuod, Elabbass
    Yassin, Mohamed A.
    [J]. BLOOD, 2021, 138
  • [6] Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
    Atteya, Asmaa
    Ahmad, Aiman
    Daghstani, Dima
    Mushtaq, Kamran
    Yassin, Mohamed A.
    [J]. CANCER CONTROL, 2020, 27 (01)
  • [7] Chennamadhavuni A., 2022, StatPearls
  • [8] Chronic Myeloid Leukemia Following Exposure to Radioactive Iodine (I 131): A Systematic Review
    Hailan, Yousef Mohammed
    Yassin, Mohamed A.
    [J]. BLOOD, 2021, 138
  • [9] CHRONIC MYELOID-LEUKEMIA FOLLOWING RADIOACTIVE IODINE I-131 THERAPY OF THYROID-CANCER
    HEGDE, UP
    GOPAL, R
    NANJANGUD, G
    ADVANI, SH
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 215 - 217
  • [10] Association of Tuberculosis in Patients with Chronic Myeloid Leukemia, a Treatment Proposal Based on Literature Review
    Iqbal, Phool
    Soliman, Ashraf Tawfiq
    Desanctis, Vincenzo
    Yassin, Mohamed A.
    [J]. BLOOD, 2020, 136
12